Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

By L. Shlush, Sasan Zandi, Amanda Mitchell, W. Chen, J. Brandwein, Vikas Gupta, J. Kennedy, A. Schimmer, A. Schuh, K. Yee and 16 more. Nature, 2014

613 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The role of mutations in epigenetic regulators in myeloid malignancies (2012, background): “(34) found that DNMT3A mutations occur before the acquisition of NPM1c and FLT3-ITD mutations in AML, and that DNMT3A mutations reside in preleukemic HSCs that later expand to form the dominant AML clone.”
Age-related clonal hematopoiesis associated with adverse outcomes. (2014, neutral): “This finding is consistent with the results of previous studies that showed that DNMT3A and TET2 mutations were frequent and early events in AML and the myelodysplastic syndrome.(9,10,14,16) Murine models of DNMT3A or TET2 loss of function have shown that mutant hematopoietic stem cells have altered”
Genomic Classification and Prognosis in Acute Myeloid Leukemia (2016, methodology): “DNMT3A TET2 ASXL1 inv(16) t(15;17) t(8;21) t(11q23;x) inv(3) t(6;9)”
A framework for data-driven analysis of materials under uncertainty: Countering the curse of dimensionality (2017, background): “…in the following fields: neuroscience with the unveiling of secrets of the brain [70]; clinical medicine [71] by finding pathways to cure cancer [72–74]; biology with explanations for the presence of microbiota in the human gut [75] and termites [76], protein analysis and genetics [77];…”